BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33867846)

  • 21. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-Regulation of miR-130b-3p Activates the PTEN/PI3K/AKT/NF-κB Pathway to Defense against
    Yuan B; Zou M; Zhao Y; Zhang K; Sun Y; Peng X
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044397
    [No Abstract]   [Full Text] [Related]  

  • 23. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
    Ke B; Shen XD; Ji H; Kamo N; Gao F; Freitas MC; Busuttil RW; Kupiec-Weglinski JW
    J Hepatol; 2012 Feb; 56(2):359-66. PubMed ID: 21756853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of miR-26a ameliorates lipopolysaccharide-induced endometritis by targeting MAP3K8 to inactivate MAPK signaling pathway.
    Huang Z; Chen Y; Yang C; Ma B; Guo S; Zhang J; Chen N; Umar T; Yin B; Deng G
    J Reprod Immunol; 2022 Dec; 154():103751. PubMed ID: 36252394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of miR-204 attenuates LPS stimulated inflammatory injury through inhibiting the Wnt/β-catenin pathway via targeting CCND2.
    Zheng Z; Wang X; Zheng Y; Wu H
    Int Immunopharmacol; 2024 Jan; 126():111334. PubMed ID: 38061119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling.
    Cheng Z; Ni Q; Qin L; Shi Y
    Braz J Med Biol Res; 2021; 54(9):e10390. PubMed ID: 34076140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream stimulatory factor 2 (USF2) induced upregulation of triggering receptor expressed on myeloid cells 1 (TREM1) promotes endometritis by regulating toll-like receptor (TLR) 2/4-nuclear factor-kappaB (NF-κB) signaling pathway.
    Zhang M; Yin C; Chen Y; Wang J; Jiang J
    Bioengineered; 2022 Feb; 13(2):3609-3619. PubMed ID: 35100093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-505 as an anti-inflammatory regulator suppresses HMGB1/NF-κB pathway in lipopolysaccharide-mediated endometritis by targeting HMGB1.
    Liu J; Guo S; Zhang T; Ma X; Wu Z; Jiang K; Zhang X; Guo X; Deng G
    Int Immunopharmacol; 2020 Nov; 88():106912. PubMed ID: 32829092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection of miR-214 against isoflurane-induced neurotoxicity involves the PTEN/PI3K/Akt pathway in human neuroblastoma cell line SH-SY5Y.
    Wu Q; Shang Y; Shen T; Liu F; Xu Y; Wang H
    Arch Biochem Biophys; 2019 Dec; 678():108181. PubMed ID: 31704096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression of long non-coding RNA SOX2 overlapping transcript attenuates lipopolysaccharide-induced injury in bronchial epithelial cells via miR-455-3p/phosphatase and tensin homolog axis and phosphatidylinositol 3-kinase/protein kinase B pathway.
    Yi C; Gu T; Li Y; Zhang Q
    Bioengineered; 2022 May; 13(5):13643-13653. PubMed ID: 35674016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
    Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
    J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-643 inhibits lipopolysaccharide-induced endometritis progression by targeting TRAF6.
    Zhao R; Wang J; Zhang X; Chen Y
    Cell Biol Int; 2020 Apr; 44(4):1059-1067. PubMed ID: 31930635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury.
    Ke B; Shen XD; Kamo N; Ji H; Yue S; Gao F; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Mar; 57(3):1203-14. PubMed ID: 23081841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
    Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
    Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Li H; Zhu X; Zhang J; Shi J
    Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-211 regulates the expression of TAB1 and inhibits the NF-κB signaling pathway in lipopolysaccharide-induced endometritis.
    Yang C; Yang C; Zhang J; Guo Y; Chen N; Yin B; Zhou Q; Zhang T; Guo S; Deng G
    Int Immunopharmacol; 2021 Jul; 96():107668. PubMed ID: 33984721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-92b acts as an oncogene by targeting PTEN/AKT in NSCLC.
    Guo JH; Fang HY; Yang JM; Liu SL; Yao QH; Fan YJ; Zhao M; Liu F; Zhang QW; Gao FH
    Cell Biochem Funct; 2020 Dec; 38(8):1100-1110. PubMed ID: 32627866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.